Subhasis Das

Employment

• University of Illinois Chicago
  2015 - Present

Education

• Loyola University Chicago Post-Doctoral Research Associate
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer
  Oncogene 2023 DOI: 10.1038/s41388-023-02633-6
  +Save
• Biogenic polymer-encapsulated diosgenin nanoparticles: Biodistribution, pharmacokinetics, cellular internalization, and anticancer potential in breast cancer cells and tumor xenograft
  Journal of Drug Delivery Science and Technology 2022 DOI: 10.1016/j.jddst.2022.103743
  +Save
• Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2 + breast cancer by ceramide-loaded nanoparticles
  Proceedings of the National Academy of Sciences 2022 DOI: 10.1073/pnas.2205454119
  +Save
• Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
  Cell Death & Disease 2022 DOI: 10.1038/s41419-022-05022-1
  +Save
• MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
  Oncogene 2021 DOI: 10.1038/s41388-021-02007-w
  +Save
• Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development.
  Cancer letters 2021 DOI: 10.1016/j.canlet.2021.04.015
  +Save
• Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells.
  Molecular pharmacology 2020 DOI: 10.1124/molpharm.120.000029
  +Save
• Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
  Oncogene 2019 DOI: 10.1038/s41388-019-0690-0
  +Save
• Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells.
  Scientific reports 2018 DOI: 10.1038/s41598-018-23780-x
  +Save
• Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
  Oncotarget 2017 DOI: 10.18632/oncotarget.16566
  +Save